Loading...

ABCL ABCELLERA BIOLOGICS INC Management Changes 8-K Filing

BCLL

BCL

ABCELLERA BIOLOGICS INC

(ABCL)

2025 8-K

Earnings Announcement

Clinical Trial Update

Patent Settlement

Earnings Report

New CMO Appointment

Financial Statements

Clinical Trials

Clinical Trials

Regulatory Compliance

Financial Statements

Earnings Results

Management Change

Earnings Announcement

Earnings Reports

Annual Meeting of Shareholders

Departure of Directors

Financial Results Announcement

Workforce Reduction

Ownership of Antibody Drug ...

Annual Meeting of Shareholders

Investment Agreement

Regulation FD Disclosure

External Links:

On November 24, 2025, AbCellera Biologics Inc. dismissed KPMG as its independent auditor and appointed Ernst & Young LLP as the new auditor for the next fiscal year, effective after KPMG completes its audit for 2025. There were no disagreements with KPMG, and the audit reports were unqualified.

AI Assistant

ABCELLERA BIOLOGICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.